Vertex Pharmaceuticals: A Look At Their Pain Therapy Program
Vertex Pharmaceuticals is diversifying from its cystic fibrosis dominance into pain and other markets. Check out our ...
Demystifying Vertex Pharmaceuticals: Insights From 17 Analyst Reviews
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $478.12, a high ...
Is Vertex Pharmaceuticals (VRTX) The Most Expensive Stock Insiders Are Dumping In March?
We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take ...
Emirates News Agency on MSN8d
DoH introduces advanced gene-editing therapy for sickle cell disease, thalassemia for first time in UAE
The innovative treatment, provided by Abu Dhabi Stem Cells Center (ADSCC), in coordination with DoH and in collaboration with ...
Nasdaq5d
Demystifying Vertex Pharmaceuticals: Insights From 17 Analyst Reviews
Vertex Pharmaceuticals is a global biotechnology ... a gene-editing therapy for beta thalassemia and sickle-cell disease. Additionally, Vertex is evaluating small-molecule inhibitors targeting ...
Gulf Today8d
Abu Dhabi introduces gene-editing therapy for sickle cell disease for first time in UAE
The Department of Health - Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has announced the ...